Original ContributionA Phase II Study of Single-Agent Oral Vinorelbine in Patients with Pretreated Advanced Non–Small-Cell Lung Cancer
References (17)
- et al.
Gemcitabine and vinorelbine as second-line therapy in non-small cell lung cancer after prior treatment taxane + platinum based regimens
Eur J Cancer
(2001) - et al.
Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy
Lung Cancer
(2001) - et al.
Second line chemotherapy with vinorelbine in the weekly monochemotherapy for the treatment of advanced non-small cell lung cancer
Lung Cancer
(1994) - et al.
A multicenter randomized phase II study of oral vs intravenous vinorelbine in advanced non-small-cell lung cancer patients
Ann Oncol
(2001) - et al.
Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicenter phase II trial
Eur J Cancer
(2004) - et al.
Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity
Lung Cancer
(2004) - et al.
Comparison of four chemotherapy regimens for advanced non-small cell lung cancer
N Engl J Med
(2002) - et al.
Randomized study of navelbine and cisplatin versus vindesine and cisplatin versus navelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients
J Clin Oncol
(1994)
There are more references available in the full text version of this article.
Cited by (0)
Electronic forwarding or copying is a violation of US and International Copyright Laws.
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by CIG Media Group, LP, ISSN #1525-7304, provided the appropriate fee is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA 978-750-8400.
Copyright © 2007 Elsevier Inc. All rights reserved.